Notably, considering the wide expression and tumorigenic function of MAPK14 across a wide variety of cancers, including breast cancer, lung cancer, and colon cancer among others, it suggests that lobeline could potentially target MAPK14 in multiple malignancies beyond CRC. The gene discussed is MAPK14; the disease is breast carcinoma.